Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its immune checkpoint inhibitor through phase 2. The asset in question, dubbed ...
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics ...
Honolulu (KHON2) – Sensei Farms is committed to aligning cutting-edge technology with environmental preservation to protect natural resources, all while optimizing food production. By combining ...
Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its options. Two weeks ago, the biotech reported phase 1/2 data for its ...
All the Latest Game Footage and Images from The Ramen Sensei 2 Noodles, soup - easy! Think again! Get your apron on, it's time to learn about the complexities and wonders that is ramen. Have what it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback